Centro di Riferimento Oncologico
Parent institution Istituti di Ricovero e Cura a Carattere Scientifico
ROR: Yes
Works count: 8,420
Citations count: 288,300
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
2012 · Rafael Rosell, Enric Carcereny, et al. · The Lancet Oncology
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
2006 · Raffaella Di Micco, Marzia Fumagalli, et al. · Nature
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 · Paolo G. Casali, N. Abecassis, et al. · Annals of Oncology